Ignite Creation Date:
2025-12-26 @ 12:18 PM
Ignite Modification Date:
2026-03-17 @ 3:12 AM
Study NCT ID:
NCT06654700
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-11-20
First Post:
2024-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell).
Sponsor:
MAXVAX Biotechnology Limited Liability Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MKKCT-100-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None